Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Browser does not support script.
Clinical Research in Southampton
Southampton Children's Hospital
A
A
A
Text only
| Accessibility | Privacy and cookies
"Helpful, informative, polite and friendly staff put my mind at ease"
Patient feedback
Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us
You are here:
Home
>
Search results
Search
Browse site A to Z
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Search results
Go To Advanced Search
Search
You could also try:
inside (292)
Mobocertinib
Description
A chemotherpay document based on Mobocertinib.
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Mobocertinib.pdf
MyelomaBortezomib IV DexamethasonePabinostatThalidomide 21day Ver1.1
Description
Chemotherapy Protocol MULTIPLE MYELOMA BORTEZOMIB (IV)-DEXAMETHASONE-PANOBINOSTAT-THALIDOMIDE Regimen (21 day) • Multipl
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaBortezomib-IV-DexamethasonePabinostatThalidomide-21day-Ver1.1.pdf
Atezolizumab1680mg
Description
Chemotherapy Protocol LUNG CANCER Atezolizumab (1680mg 28 days) Regimen • Lung – Atezolizumab Indication • Atezolizu
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Atezolizumab1680mg.pdf
MyelomaBortezomib SC DexamethasonePabinostatThalidomide 21day Ver1.1
Description
Chemotherapy Protocol MULTIPLE MYELOMA BORTEZOMIB (SC)-DEXAMETHASONE-PANOBINOSTAT-THALIDOMIDE Regimen (21 day) • Multipl
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaBortezomib-SC-DexamethasonePabinostatThalidomide-21day-Ver1.1.pdf
Bosutinib
Description
Chemotherapy Protocol Chronic Myeloid Leukaemia Bosutinib Regimen • Bosutinib Indication • As an option for the treatment of patients with chronic p
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Bosutinib.pdf
UHS RD Small Grants Scheme 2021_application_form
Description
UHS R&D Small Grants Scheme 2021 University Hospital Southampton NHS Foundation Trust (UHS) R&D is seeking grant applications from investigators across the South
Url
/Media/Southampton-Clinical-Research/UHS-RD-Small-Grants-Scheme-2021-application-form.docx
UHS RD Small Grants Scheme 2021_application_form
Description
UHS R&D Small Grants Scheme 2021 University Hospital Southampton NHS Foundation Trust (UHS) R&D is seeking grant applications from investigators across the South
Url
/Media/Southampton-Clinical-Research/Grants/Download/UHS-RD-Small-Grants-Scheme-2021-application-form.docx
Electrophysiology study - patient information
Description
Information about having an electrophysiology study
Url
/Media/UHS-website-2019/Patientinformation/Heartandlungs/Electrophysiologystudy-723-PIL.pdf
Acalabrutinib
Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Regimen Acalabrutinib • CLL – Acalabrutinib Indication • First-line treat
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Acalabrutinib.pdf
Elranatamab
Description
Chemotherapy Protocol ELRANATAMAB This protocol may require funding Regimen • Elranatamab Indication • Monotherapy for the
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Elranatamab-Ver2.pdf
171
to
180
of
1000
Previous
…
16
17
18
19
20
…
Next
Site policies
Report a problem with this page
Privacy and cookies
Site map
Translation
Last updated: 14 September 2019
Contact details
University Hospital Southampton NHS Foundation Trust
Tremona Road
Southampton
Hampshire
SO16 6YD
Telephone: 023 8077 7222
Useful links
Home
Getting here
What to do in an emergency
Research
Working here
Education
© 2014 University Hospital Southampton NHS Foundation Trust
Browser does not support script.
Browser does not support script.